Tiziana Life Sciences Ltd
TLSA
$1.18
$0.054.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.46M | 2.46M | 2.97M | 2.97M | 3.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.97M | 5.97M | 4.59M | 4.59M | 4.64M |
| Operating Income | -5.97M | -5.97M | -4.59M | -4.59M | -4.64M |
| Income Before Tax | -6.40M | -6.40M | -2.82M | -2.82M | -4.38M |
| Income Tax Expenses | -- | -- | -- | -- | -778.50K |
| Earnings from Continuing Operations | -6.40M | -6.40M | -2.82M | -2.82M | -3.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.40M | -6.40M | -2.82M | -2.82M | -3.60M |
| EBIT | -5.97M | -5.97M | -4.59M | -4.59M | -4.64M |
| EBITDA | -5.97M | -5.97M | -4.59M | -4.59M | -4.64M |
| EPS Basic | -0.05 | -0.05 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.05 | -0.05 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 119.74M | 119.74M | 116.83M | 116.83M | 110.25M |
| Average Diluted Shares Outstanding | 119.74M | 119.74M | 116.83M | 116.83M | 110.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |